Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication

Europace

Volumn 15, Issue 6, 2013, Pages 820-826

  Lüsebrink, Ulrich ^a   Duncker, David ^a   Hess, Michaela ^a   Heinrichs, Irma ^a   Gardiwal, Ajmal ^a   Oswald, Hanno ^a   König, Thorben ^a   Klein, Gunnar ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Heart failure; ICD; Slow VT; Ventricular arrhythmia

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; EVENT FREE SURVIVAL; FAINTNESS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART PALPITATION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; SMOKING CESSATION; TREATMENT INDICATION;

HEART FAILURE; ICD; SLOW VT; VENTRICULAR ARRHYTHMIA;

ADULT; AGED; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; SURVIVAL ANALYSIS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84878300788     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus430     Document Type: Article

References (23)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-442.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med 1996;335:1933-40.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
6. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the Detect Supraventricular Tachycardia Study. Circulation 2006;113:2871-9.
7. Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P et al. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Europace 2009;11:587-93.
8. Bänsch D, Steffgen F, Grönefeld G, Wolpert C, Böcker D, Mletzko RU et al. The 1 + 1 trial: a prospective trial of a dual-versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation 2004;110:1022-9.
9. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-65.
10. Prochaczek F, Winiarska H, Gałecka J, Trusz-Gluza M. [Termination of slow ventricular tachycardia which is below ICD detection rate-a case report]. Kardiol Pol 2009;67:1292-5.
11. Del Rosso A, Guarnaccia V, Borselli F, Petix NR, Bartoli P. [Incessant slow ventricular tachycardia in ischemic cardiomyopathy]. G Ital Cardiol (Rome) 2010;11: 43-4.
12. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-62.
13. McMurray JJV. Systolic heart failure. N Engl J Med 2010;362:228-38.
14. Talajic M, Khairy P, Levesque S, Connolly SJ, Dorian P, Dubuc M et al. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol 2010;55:1796-1802.
15. Neuberger HR, Mewis C, van Veldhuisen DJ, Schotten U, van Gelder IC, Allessie MA et al. Management of atrial fibrillation in patients with heart failure. Eur Heart J 2007;28:2568-77.
16. Borleffs CJ, van Rees JB, van Welsenes GH, van der Velde ET, van Erven L, Bax JJ et al. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:879-85.
17. Grönefeld GC, Mauss O, Li Y-G, Klingenheben T, Hohnloser SH. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol 2000;11:1208-14.
18. Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M et al. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT Study. Europace 2006;8:618-24.
19. Gold MR, Linde C, Abraham WT, Gardiwal A, Daubert J-C. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm 2011;8:679-84.
20. Hoppe UC, Casares JM, Eiskjaer H, Hagemann A, Cleland JG, Freemantle N et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006;114:18-25.
21. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-17.
22. Larsen GK, Evans J, Lambert WE, Chen Y, Raitt MH. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2011;8: 1881-6.
23. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010;7:353-60.